Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?
223
TL;DR: Current evidence on the interaction between gut permeability and intestinal as well as extra-intestinal bacteria and their joint contributions to systemic inflammation and metabolism are reviewed, focusing specifically on gut microbiota shifts, and limitations of current studies are addressed.
read more
Abstract: The emerging evidence on the interconnectedness between the gut microbiome and host metabolism has led to a paradigm shift in the study of metabolic diseases such as obesity and type 2 diabetes with implications on both underlying pathophysiology and potential treatment. Mounting preclinical and clinical evidence of gut microbiota shifts, increased intestinal permeability in metabolic disease, and the critical positioning of the intestinal barrier at the interface between environment and internal milieu have led to the rekindling of the "leaky gut" concept. Although increased circulation of surrogate markers and directly measurable intestinal permeability have been linked to increased systemic inflammation in metabolic disease, mechanistic models behind this phenomenon are underdeveloped. Given repeated observations of microorganisms in several tissues with congruent phylogenetic findings, we review current evidence on these unanticipated niches, focusing specifically on the interaction between gut permeability and intestinal as well as extra-intestinal bacteria and their joint contributions to systemic inflammation and metabolism. We further address limitations of current studies and suggest strategies drawing on standard techniques for permeability measurement, recent advancements in microbial culture independent techniques and computational methodologies to robustly develop these concepts, which may be of considerable value for the development of prevention and treatment strategies.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Immunologic Effects of Vitamin D on Human Health and Disease
TL;DR: It is advisable to increase vitamin D intake and have sensible sunlight exposure to maintain serum 25-hydroxyvitamin D at least 30 ng/L, and preferably at 40–60 ng/mL (100–150 nmol/L) to achieve the optimal overall health benefits of vitamin D.
774
Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice.
Lingyan Ma,Yinhua Ni,Zhe Wang,Tu Wenqing,Liyang Ni,Fen Zhuge,Aqian Zheng,Luting Hu,Yufeng Zhao,Liujie Zheng,Zhengwei Fu +10 more
TL;DR: It is shown that spermidine intake is negatively correlated with obesity in both humans and mice, and that sPermidine supplementation may serve as a viable therapy for obesity.
378
Microbiota-derived extracellular vesicles in interkingdom communication in the gut.
TL;DR: In this article, the authors review current knowledge on microbiota EVs and specifically highlight their role in controlling host metabolism, intestinal barrier integrity and immune training, and highlight their importance in the development of the human intestine.
204
Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders
TL;DR: The authors in this article provide a broad insight into the microbiome signatures linked to inflammatory and metabolic disorders, discuss outstanding challenges in this field and propose applications of multi-omics technologies that could lead to an improved mechanistic understanding of microorganism-host interactions.
160
The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis
Patricia Martins Bock,Patricia Martins Bock,Gabriela H. Telo,Rafaela Ramalho,Mariana Sbaraini,Gabriel Leivas,Andreza Francisco Martins,Beatriz D'Agord Schaan,Beatriz D'Agord Schaan +8 more
TL;DR: It is suggested that consumption of probiotics, prebiotics or synbiotics may be a potential adjuvant treatment for improving metabolic outcomes in individuals with diabetes mellitus.
References
T84 monolayers are superior to Caco-2 as a model system of colonocytes.
Sarah Devriese,Lien Van den Bossche,Sophie Van Welden,Tom Holvoet,Iris Pinheiro,Pieter Hindryckx,Martine De Vos,Debby Laukens +7 more
TL;DR: In this article, the authors compared Caco-2 and T84 epithelial cells and found that T84 cells exhibited a dose-responsive improvement of barrier function towards butyrate.
82
Colonic Pro-inflammatory Macrophages Cause Insulin Resistance in an Intestinal Ccl2/Ccr2-Dependent Manner
Yoshinaga Kawano,Jun Nakae,Nobuyuki Watanabe,Tetsuhiro Kikuchi,Sanshiro Tateya,Yoshikazu Tamori,Mari Kaneko,Takaya Abe,Masafumi Onodera,Hiroshi Itoh +9 more
TL;DR: In this paper, the authors showed that colonic pro-inflammatory macrophages regulate insulin sensitivity under high-fat diet conditions, and they showed that inhibition of macrophage infiltration prevents HFD-induced insulin resistance and could be a novel therapeutic approach for type 2 diabetes.
82
Intestinal fatty acid-binding protein as a sensitive marker of intestinal ischemia.
Tatsuo Kanda,Yasuo Nakatomi,Hiroyuki Ishikawa,Masahiro Hitomi,Yoichi Matsubara,Teruo Ono,Terukazu Muto +6 more
TL;DR: Observations strongly suggest that the intestinal fatty acid-binding protein is a useful biochemical marker for intestinal ischemia, particularly in the early reversible phase.
82
Angptl4 serves as an endogenous inhibitor of intestinal lipid digestion
Frits Mattijssen,Sheril Alex,Hans J. M. Swarts,Albert K. Groen,Evert M. van Schothorst,Sander Kersten +5 more
TL;DR: Evidence is presented that recombinant Angptl4 reduced the activity of pancreatic lipase as well as the lipase activity in human ileostomy output and suggests that Angiopoietin-like 4 is an endogenous inhibitor of intestinallipase activity.
81
Early endotoxemia increases peripheral and hepatic insulin sensitivity in healthy humans
Saskia N. van der Crabben,Regje M. E. Blümer,Michiel E. Stegenga,Mariëtte T. Ackermans,Erik Endert,Michael W.T. Tanck,Mireille J. Serlie,Tom van der Poll,Hans P. Sauerwein +8 more
TL;DR: These data indicate that shortly (2 h) after administration of LPS, peripheral and hepatic insulin sensitivity increase, which may contribute to the hypoglycemia occurring in some patients with critical illness, especially in the setting of intensive insulin therapy.
79
Related Papers (5)
Patrice D. Cani,Jacques Amar,Miguel A. Iglesias,Marjorie Poggi,Claude Knauf,Delphine Bastelica,Audrey M. Neyrinck,Francesca Fava,Kieran Tuohy,Chantal Chabo,Aurélie Waget,Evelyne Delmée,Béatrice Cousin,Thierry Sulpice,Bernard Chamontin,Jean Ferrières,Jean-François Tanti,Glenn R. Gibson,Louis Casteilla,Nathalie M. Delzenne,Marie-Christine Alessi,Rémy Burcelin +21 more